GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Pretax Margin %

Virbac (Virbac) Pretax Margin % : 17.92% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Virbac Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Virbac's Pre-Tax Income for the six months ended in Jun. 2023 was $119 Mil. Virbac's Revenue for the six months ended in Jun. 2023 was $661 Mil. Therefore, Virbac's pretax margin for the quarter that ended in Jun. 2023 was 17.92%.

The historical rank and industry rank for Virbac's Pretax Margin % or its related term are showing as below:

VRBCF' s Pretax Margin % Range Over the Past 10 Years
Min: 1.8   Med: 10.64   Max: 18.55
Current: 14.75


VRBCF's Pretax Margin % is ranked better than
73.87% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 4.555 vs VRBCF: 14.75

Virbac Pretax Margin % Historical Data

The historical data trend for Virbac's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Pretax Margin % Chart

Virbac Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.71 8.28 18.55 14.95 14.51

Virbac Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.99 10.95 17.42 11.52 17.92

Competitive Comparison of Virbac's Pretax Margin %

For the Drug Manufacturers - General subindustry, Virbac's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Virbac's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Virbac's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Virbac's Pretax Margin % falls into.



Virbac Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Virbac's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=186.91/1288.334
=14.51 %

Virbac's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=118.531/661.395
=17.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Virbac  (OTCPK:VRBCF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Virbac Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Virbac's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac (Virbac) Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (Virbac) Headlines

From GuruFocus

Full Year 2022 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2022 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Virbac SA SFAF Meeting Transcript

By GuruFocus Research 03-08-2024

Full Year 2018 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024